• Novel mRNA therapy restores GALT protein and enzyme activity in a zebrafish model of classic galactosemia. 
    Delnoy B, Haskovic M, Vanoevelen J, Steinbusch LKM, Vos EN, Knoops K, Zimmermann LJI, Noga M, Lefeber DJ, Martini PGV, Coelho AI, Rubio-Gozalbo ME.
    J Inherit Metab Dis. 2022 Jul;45(4):748-758. doi: 10.1002/jimd.12512. Epub 2022 May 27. PMID: 35527402. Pubmed

  • DTYMK is essential for genome integrity and neuronal survival. 
    Vanoevelen JM, Bierau J, Grashorn JC, Lambrichs E, Kamsteeg EJ, Bok LA, Wevers RA, van der Knaap MS, Bugiani M, Frisk JH, Colnaghi R, O'Driscoll M, Hellebrekers DMEI, Rodenburg R, Ferreira CR, Brunner HG, van den Wijngaard A, Abdel-Salam GMH, Wang L, Stumpel CTRM.
    Acta Neuropathol. 2022 Feb;143(2):245-262. doi: 10.1007/s00401-021-02394-0. Epub 2021 Dec 17. PMID: 34918187. Pubmed

  • Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer-induced cachexia.
    Rianne D.W. Vaes, David P.J. van Dijk, Tessa T.J. Welbers, Marinus J. Blok, Merel R. Aberle, Lara Heij, Sylvia F. Boj, Steven W.M. Olde Damink, Sander S. Rensen
    Journal of Cachexia, Sarcopenia and Muscle, 13 October 2020. Full text

Sluit de enquête